VU University, Amsterdam
Findings in lung cancer provide new insights
Published in Medical Imaging Business Week, March 16th, 2006
Study 1: The use of [F-18]-2-fluoro-2-deoxy-D-glucose positron emission tomography [(18)FDG PET] in patients with non-small-cell lung cancer (NSCLC) was assessed.
"The objective of this study was to determine the accuracy of (early) response measurements using (18)FDG-PET with respect to survival of patients with stage IIIA-N2 NSCLC undergoing induction chemotherapy (IQ, with a comparative analysis of PET methods. In a prospective multicenter study, PET was performed in patients before IC and after 1 and 3 cycles. Computed tomography (CT) was performed before...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
More Articles from Medical Imaging Business Week
- CardioDynamics
CardioDynamics reports 21% decrease in sales - EPIX Pharmaceuticals, Inc.
Thrombus program moves forward; patent granted for peptide-based contrast agents - Nuance Communications, Inc.
Kaiser medical center selects speech recognition application for medical professionals - Precision Optics Corporation, Inc.
Precision Optics Corporation announces revenues of $529,195 - Viatronix, Inc.
Diagnostic imaging software company Viatronix names Jan F. Jumet, JD, chairman of board - Athens Medical School
In acute coronary syndrome, plaque temperature is elevated in nonculprit atheromatous lesions - More from this issue of Medical Imaging Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
